Medrad mobilizes MRI injector

Article

Spectris has gone mobile. The injector of MRI contrast media has been adapted by Medrad for use in the tight quarters of MRI trailers. This configuration has a space-saving base-plate that secures the injector to the wall and a transportation clamp that

Spectris has gone mobile. The injector of MRI contrast media has been adapted by Medrad for use in the tight quarters of MRI trailers. This configuration has a space-saving base-plate that secures the injector to the wall and a transportation clamp that also secures the injector head to the wall for easy and safe transport. It is compatible with the four major mobile trailer manufacturers: Calumet Coach, Medical Coaches, AK Associates, and Ellis & Watts. The mobile configuration is currently available in North America and will roll out in Europe, Latin America, and Japan at a later date.

© 2001 Miller Freeman Inc.
3/28/01, Issue # 1506, page 6.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.